SEOUL, July 19 (Korea Bizwire) — South Korea will push to designate biopharmaceutical manufacturing as a national strategic technology, and extend support for the development of indigenous raw materials and equipment in the field with a goal to become the world’s top biotech economy by 2030, the industry ministry said Wednesday. The move is part [...]
SEOUL, Jan. 11 (Korea Bizwire) — SK Pharmteco Inc., a biopharmaceutical arm of South Korea’s No. 3 conglomerate SK Group, aims to generate US$2 billion in annual sales in the next three years with a focus on cell and gene therapy business, its parent company SK Inc. said Tuesday. Aslam Malik, CEO of SK’s contract [...]
SEOUL, July 26 (Korea Bizwire) — South Korea’s exports of biopharmaceutical products more than doubled in 2020 from a year earlier on the back of the growing demand for pharmaceutical products amid the COVID-19 pandemic, a report showed Monday. Outbound shipments of high-end biopharmaceutical products came to US$5.1 billion in 2020, compared with around $2.1 [...]
NEW YORK, Jan. 7 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that the ongoing multi-center clinical trial of CK-301 has been expanded to enroll patients in three cohorts intended to [...]
LONDON, Jan. 4 (Korea Bizwire) – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis today provides a business update and announces a Company change of name from Pro Bono Bio. BUSINESS UPDATE Haemophilia SelectAte Phase II clinical development programme initiated to [...]
LONDON, Jun. 22 (Korea Bizwire) – Autolus Therapeutics plc (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530 ordinary shares at an initial public offering price of $17.00 per ADS for total [...]
SEOUL, Feb. 21 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc.’s biosimilar drug Truxima will reach the Colombian market, the company’s affiliate said Wednesday. Global drug firm Mundi Pharma Inc. won exclusive rights to distribute and market the copy of Roche’s blockbuster medicine, also known as MabThera, in the South American country, Celltrion Healthcare [...]
SEOUL, Jan. 8 (Korea Bizwire) — The head of a biotech venture firm has emerged as the fourth-richest man in stock holdings in South Korea, industry data showed Sunday, amid a bio venture boom in Asia’s fourth-biggest economy. The value of stocks held by Seo Jung-jin, chairman of biopharmaceutical firm Celltrion Inc., rose to 5.39 [...]
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 10 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today provided an update on key programs, potential milestones [...]
SEOUL, Apr. 12 (Korea Bizwire) — South Korea is set to release a set of support measures, including nurturing talented manpower, to help local pharmaceutical companies make further inroads into the global market, the country’s health minister said Tuesday. The remarks were made during a meeting attended by Health Minister Chung Chin-yeob, and executives of [...]